Biosimilars: Are They Delivering the Cost Savings Promised?
Since the first FDA biosimilar approval of filgrastim-sndz (Zarxio) in 2015, a total of 44 biosimilars for 15 originator products have been approved and more than 20 are marketed.
United States Megan Holsopple Neulasta Onpro Vizient Biosimilar Client Programs At Arrive Health Drug Administration
Source: pharmacytimes.com